Play
Pause
Stop
Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer
3
Jan 28, 2023
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Volume 21, Issue 1, 2023 Feb, Pages 183 193 | Nindra, Udit; Hong, Jun Hee; Balakrishnar, Bavanthi;...
There is emerging evidence for the use of poly (ADP ribose) polymerase inhibitors (PARPi) in patients with mCRPC with patients harboring germline or somatic mutations deriving clinical benefit. However, the toxicity profile of PARPi in mCR...
Please Log In to leave a comment.